DFX Intelligence
The names on this page are hidden. Create a free account to reveal 5 records a month, or get RIA and Wealth Intelligence at $249 a month for every name. Every figure, date and source on this page is public either way.
Private fund
B•• H•••••• F•••• L•• • D•• N••••••••• S•••••
Other Private Fundadvised byB•••••• G••••• A•••••••• L••independent RIA805-2123497115no longer reportedIAPD
Gross asset value
$400,000
as of Nov 4, 2021; not a fund size
Peak GAV
$4.7M
highest filing
Owners
20
beneficial owners reported
Minimum investment
Not disclosed
as reported
Adviser and related own
31%
of the fund
Owned by funds
0%
fund-of-funds interests
Non-US owners
3%
Reported
17 filings
Mar 27, 2014 to Nov 4, 2021
Reporting history
one row per Form ADV filing
Gross asset value$400,000 as of Nov 4, 2021
Mar 27, 2014$4.0M then
Owners20 as of Nov 4, 2021
Mar 27, 201420 then
Structure
- Exclusion
- 3(c)(7), qualified purchasersreported
- Master or feeder
- standalonereported
- Fund of funds
- yesreported
- Organized in
- Delaware, United Statesreported
- Clients solicited
- yes, 12% of the adviser's clients investedreported
- Form D file number
- 021-213547reportedthe join to the Form D offering
- Type as written
- PHARMACEUTICAL ROYALTIESreported
Custodians
Schedule D 7.B.(1).A.25, latest filing
- N••••••• F•••••••• S••••••• L••Boston, Massachusetts
Across DFX
shared identifiers only
This fund id is not on the venture or private equity graphs.
Provenance
- Source
- Form ADV Schedule D 7.B.(1), every filing 2011 to 2024reportedadviserinfo.sec.gov
- Status
- not on the adviser's later filingsderived
- Share
- 31%reportedadviser and related persons